AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
Prevalence was generally higher among women and clinical populations, highlighting the need for targeted screening and prevention, and heterogeneity was generally higher among women and clinical populations.
Background: The relationship between metabolic syndrome (MetS) and Alzheimer disease (AD) has gained increasing attention in recent years, reflecting the growing recognition of metabolic factors in neurodegenerative conditions. The present study aims to estimate the prevalence of MetS in patients with AD. Methods: A sy...
Metabolic syndrome (MetS) is common in Chinese adults, but evidence regarding its burden and cardiovascular relevance among young healthcare workers (HCWs) remains limited. Different MetS definitions can yield materially different prevalence estimates and risk classifications. This retrospective cross-sectional study i...
Background: Metabolic syndrome (MetS) is a growing public health challenge globally, with particularly high and rising prevalence in rapidly urbanizing nations like India. Characterized by a cluster of interrelated metabolic abnormalities, MetS significantly elevates risk of type 2 diabetes mellitus and cardiovascular...
Background Metabolic syndrome (MetS) refers to a constellation of cardiometabolic risk factors that increase the risk of cardiovascular diseases and type 2 diabetes (T2DM). This study estimated the prevalence of MetS and its associated factors in young adults in the United Arab Emirates (UAE). Methods This was a cross-...
Background Obesity has emerged as a global public health pandemic, with rapidly increasing prevalence and a growing burden of obesity-related chronic diseases worldwide. Despite its high prevalence, obesity remains underdiagnosed, limiting effective prevention and management. Reliable, region-specific epidemiological d...
Lung cancer has a 29% survival rate, with nearly half detected at Stage 4. Survival increases to 65% with early-stage diagnosis, yet only 28.1% are diagnosed early. Cardiovascular and respiratory comorbidities coexist with LC and may affect detection and prognosis. Metabolic syndrome (MetS), characterized by central ad...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.